PayerTalkCE cover art

All Episodes

PayerTalkCE — 41 episodes

#
Title
1

Bridging the Gaps: Improving Access and Timely Diagnosis for Retinal Diseases

2

Aligning Policy with Practice: What Providers Need from Payers in Retinal Disease Management

3

Payer/Provider Collaboration to Meet Best Practice Standards in Asthma Management - Special CareTeamTalk Edition

4

PayerTalkCE® Presents: Navigating the Complexities of Hypertrophic Cardiomyopathy

5

PayerTalkCE® Presents: Emerging HER2-targeting Therapies for the Management of GI Cancers

6

PayerTalkCE® Presents: Trends in Cancer Care: Precision Oncology in Rare GI Cancers

7

PayerTalkCE® Presents: Managed Care Strategies to Improve Outcomes for Macular Telangiectasia

8

PayerTalkCE® Presents: Understanding T2 Inflammation: Best Practices in COPD Management

9

PayerTalkCE® Presents: Understanding Type 2 Inflammation: Spotlight on COPD

10

PayerTalkCE® Presents: Case Challenge: Age-Related Macular Degeneration

11

PayerTalkCE® Presents: Case Challenge: T1 Diabetes Patient with Diabetic Retinopathy

12

PayerTalkCE® Presents: Understanding Type 2 Inflammation: Best Practices in Moderate-to-Severe Asthma Management

13

PayerTalkCE® Presents: Understanding Type 2 Inflammation: Spotlight on Moderate-to-Severe Asthma

14

PayerTalkCE® Presents: Understanding Type 2 Inflammation: Best Practices in Atopic Dermatitis Management

15

PayerTalkCE® Presents: Understanding Type 2 Inflammation: Spotlight on Atopic Dermatitis

16

PayerTalkCE® Presents: Managing DR/DME for Underserved Populations

17

PayerTalkCE® Presents: Care Coordination for a Patient with AMD and Multiple Comorbid Conditions

18

PayerTalkCE™ Presents: Understanding Type 2 Inflammation: Best Practices in EoE Management

19

PayerTalkCE™ Presents: Understanding Type 2 Inflammation - Spotlight on Eosinophilic Esophagitis

20

PayerTalkCE™ Presents: Advancing Equity: Pediatric Atopic Dermatitis Management in Managed Care

21

PayerTalkCE™ Presents: Diabetes Quality Management–Trends and Opportunities for Continuous Glucose Monitoring in Managed Care Pharmacy

22

PayerTalkCE™ Presents: Current Strategies to Optimize Clinical, Economic, and Humanistic Outcomes in Multiple Sclerosis

23

PayerTalkCE™ Presents: Balancing Cost and Access to Quality Care for Therapeutic Advancements in Psoriasis

24

PayerTalkCE™ Presents: Addressing Unmet Needs in AMD and DME

25

PayerTalkCE™ Presents: Achieving Appropriate and Equitable Treatment Access for Prostate Cancer Care

26

PayerTalkCE™ Presents: Innovations in the Retinal Disease Treatment Paradigm

27

PayerTalkCE™ Presents: Improving the Utilization Management Process in Atopic Dermatitis

28

PayerTalkCE™ Presents: Impact of An Aging US Population on Retinal Diseases

29

PayerTalkCE™ Presents: Continuous Glucose Monitoring: Improving Access to CGM Under the Pharmacy Benefit

30

PayerTalkCE™ Presents: Access and Utilization Strategies for the Management EoE

31

PayerTalkCE™ Presents: Understanding Best Practices in Access to Pediatric Dermatologic Care for Children Living with Atopic Dermatitis

32

PayerTalkCE™ Presents: Major Advances in the Management of Retinopathy of Prematurity (ROP)

33

PayerTalkCE Presents: Managing Eosinophilic Esophagitis (EoE): Collaborative Care and the Patient Journey

34

PayerTalkCE Presents: Interpreting A Complex Puzzle: US Commercial Payer Coverage of Atopic Dermatitis (AD) Treatments Varies Widely

35

PayerTalkCE Presents: Access and Utilization Strategies for the Management of Specialty Drugs in Atopic Dermatitis

36

PayerTalkCE Presents: Tackling the Clinical, Economic, and Humanistic Burden of Atopic Dermatitis

37

PayerTalkCE Presents: Real-time Continuous Glucose Monitoring Impact on Glycemic Control and Acute Metabolic Events

38

PayerTalkCE Presents: Health Plan Strategies for Quality Improvement in Underserved Populations with Diabetes

39

PayerTalkCE Presents: Health Plan Implementation Recommendations for rtCGM

40

PayerTalkCE Presents: The Rapidly Evolving Atopic Dermatitis Treatment Paradigm

41

PayerTalkCE Presents: Applying Real-World Experience to Better Manage the Use of Oncology Biosimilars